Pharmaceutical - AstraZeneca, Healthcare

Filter

Current filters:

AstraZenecaHealthcare

Popular Filters

New ACC and AHA guidelines could increase sales of statins

New ACC and AHA guidelines could increase sales of statins

13-11-2013

New clinical guidelines have been published for the treatment of cholesterol in people at high risk of…

AbbVieAstraZenecaCardio-vascularCrestorHealthcareLipitorMerck & CoNorth AmericaPfizerPharmaceuticalTricorUSAZetia

EXPERT VIEW: AstraZeneca warns of

EXPERT VIEW: AstraZeneca warns of "significant risk to health" from antimicrobial resistance

13-09-2013

One of the UK's leading pharma companies has expressed its support for the Department of Health's five…

AstraZenecaEuropeHealthcareInterviewsPharmaceutical

Proposal to list AstraZeneca's Brilinta in New Zealand

26-03-2013

New Zealand's Pharmaceutical Management Agency, PHARMAC, is seeking feedback on a proposal to fund the…

Asia-PacificAstraZenecaBrilintaCardio-vascularFinancialHealthcarePharmaceuticalPricingticagrelor

Big Pharma doing more for access to medicine in developing countries than two years ago

28-11-2012

The latest Access to Medicine Index, which ranks the top 20 pharmaceutical companies on their efforts…

AstraZenecaBayerGlaxoSmithKlineGlobalHealthcareJohnson & JohnsonMerck KGaAPharmaceuticalPricingResearch

UK to implement child flu vaccines program

25-07-2012

UK Health Secretary Andrew Lansley yesterday accepted recommendations from UK immunization experts to…

Anti-viralsAstraZenecaFluenzHealthcarePharmaceuticalVaccines

AstraZeneca links with IMS on real-world evidence

11-01-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) has entered into a three-year collaboration agreement…

AstraZenecaEuropeHealthcarePharmaceuticalResearch

Parexel

Parexel

Back to top